Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.87 USD | +7.39% | +14.47% | +52.63% |
May. 14 | Viracta Therapeutics Appoints Michael Faerm CFO | MT |
May. 14 | Viracta Therapeutics, Inc. Appoints Michael Faerm as Chief Financial Officer | CI |
- Stock Market
- Equities
- VIRX Stock
- News Viracta Therapeutics, Inc.
- MarketScreener Editorial Features